Skip to content

The effects of transcranial direct current stimulation combined with exercise therapy on clinical outcomes

The effects of transcranial direct current stimulation combined with exercise therapy on pain, function and central pain inhibition mechanisms in subjects with Patellofemoral Pain: A clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191221045836N1
Enrollment
32
Registered
2020-01-27
Start date
2020-01-10
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral pain. Pain in knee

Interventions

Intervention group: Combined exercise therapy and transcranial direct current stimulation Control group: Exercise therapy.

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Anterior knee pain Provoked pain with two physical activity of functional tasks: stairs climbing, squat, running, biking, jumping, prolonged sitting Painfull quadriceps isometric contraction at 60 degree of squat Pain with medial or lateral patellar facet palpation Minimal pain intensity with visual analog scale 3 of 10 Pain report more than 3 years

Exclusion criteria

Exclusion criteria: History of knee surgery ligament knee instability Meniscus injury symptoms or intra joint dysfunction Knee tendinitis ( patellat tendinitis, iliotibial band and jumper's knee tendinitis, Pes anserinus tendinitis) Patients with Osgood-Shlatter or Sinding-Larsen-Johanssen Patellar instability and positive apprehension sign Traumatic patellar dislocation Concurrent pain in hip, sacroiliac & lumbar walking with assistance Systematic disorders (cardiovascular or rheumatology) that affect on lower limbs Knee structural disorders including knee varus and valgus Psychiatry disorders that affect on electroencephalography such as depression, autism, Schizophrenia Seizure and epilepsy

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 1 day before first session of treatment, second and twenty first days after end of treatment. Method of measurement: Visual Analog Scale.;Functional level. Timepoint: 1 day before first session of treatment, second and twenty first days after end of treatment. Method of measurement: Lower limb functional scale questioner.;Pressure pain threshold. Timepoint: 1 day before first session of treatment, second and twenty first days after end of treatment. Method of measurement: Lutron tension and compression force gauge.;Conditioned pain modulation. Timepoint: 1 day before first session of treatment, second and twenty first days after end of treatment. Method of measurement: Conditioned pain modulation test score.;Kinesiophobia. Timepoint: 1 day before first session of treatment, second and twenty first days after end of treatment. Method of measurement: Tampa Scale for Kinesiophobia questioner.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForuzan Orak

Ahvaz University of Medical Sciences

orak.f@ajums.ac.ir+98 61 3374 3101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026